SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 1-A/A - Offering Statement [Regulation A]: [Amend]
SEC Accession No. 0001683168-18-003156
Filing Date
2018-10-26
Accepted
2018-10-26 15:16:25
Documents
5

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 1-A/A  
1 primary_doc.xml 1-A/A 15172
2 POC AMEND NO. 3 cns_1aa3.htm PART II AND III 26829
3 ACCOUNTING LETTER cns_1aa3-ex0901.htm EX1A-9 ACCT LTR 2418
4 OPINION cns_1aa3-ex1201.htm EX1A-12 OPN CNSL 15731
5 GRAPHIC image_001.jpg GRAPHIC 24957
  Complete submission text file 0001683168-18-003156.txt   95759
Mailing Address 2100 WEST LOOP SOUTH SUITE 900 HOUSTON TX 77027
Business Address 2100 WEST LOOP SOUTH SUITE 900 HOUSTON TX 77027 1-800-946-9185 X701
CNS Pharmaceuticals, Inc. (Filer) CIK: 0001729427 (see all company filings)

IRS No.: 822318545 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 1-A/A | Act: 33 | File No.: 024-10855 | Film No.: 181141509
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1